US Stock MarketDetailed Quotes

Ultragenyx Pharmaceutical (RARE)

Watchlist
  • 23.300
  • -0.610-2.55%
Close Apr 10 15:59 ET
  • 23.260
  • -0.040-0.17%
Post 20:01 ET
2.29BMarket Cap-4.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical (RARE) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Research, development and commercialization of its products673M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
North America377M56.02%
Latin America170M25.26%
Europe, Middle East, and Africa108M16.05%
Asia-Pacific18M2.67%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -